Atyr Pharma Inc (ATYR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2020 | 12-2019 | 09-2019 | 06-2019 | 03-2019 | |
| Sales | 8,065 | 144 | 184 | 94 | 0 |
| Gross Profit | 8,065 | 144 | 184 | 94 | N/A |
| Operating Expenses | 6,206 | 6,106 | 5,682 | 5,735 | 5,877 |
| Operating Income | 1,859 | -5,962 | -5,498 | -5,641 | -5,877 |
| Other Income | -107 | -171 | -147 | -207 | -260 |
| Pre-tax Income | 1,752 | -6,133 | -5,645 | -5,848 | -6,137 |
| Net Income Continuous | 1,752 | -6,133 | -5,645 | -5,848 | -6,137 |
| Minority Interests | 1 | N/A | N/A | N/A | N/A |
| Net Income | $1,751 | $-5,973 | $-5,645 | $-5,848 | $-6,137 |
| EPS Basic Total Ops | 0.25 | -1.22 | -1.47 | -1.80 | -2.54 |
| EPS Basic Continuous Ops | 0.25 | -1.27 | -1.47 | -1.80 | -2.54 |
| EPS Diluted Total Ops | 0.25 | -1.22 | -1.47 | -1.80 | -2.54 |
| EPS Diluted Continuous Ops | 0.25 | -1.27 | -1.47 | -1.80 | -2.54 |
| EBITDA(a) | $2,322 | $-5,498 | $-5,033 | $-5,212 | $-5,446 |